DHA sbir PH II medical r & d contract for proposal no. H2-0440, titled: "broad spectrum envenomation treatment".
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH19C0082
- Awardee
-
Ophirex, Inc. UEI W452WY5E2JQ9
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,525,195
Award facts
- Opportunity
-
- HQ003418R1ADB Solicitation number
- Contract value 100% obligated
- $1,525,194.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 14 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Corte Madera, CA 94925, USA
- Research
- SBIR Program Phase II Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $549,699 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $975,496 |
About this award
This is a Small Business Innovation Research (SBIR) Phase II medical research and development contract awarded by the Defense Health Agency (DHA) to Ophirex, Inc., a small business located in Corte Madera, California. The contract, valued at $1,525,194.76, is for the development of a "Broad Spectrum Envenomation Treatment" to address snakebite injuries. The contract has a firm fixed price and a total small business set aside designation. This contract builds upon previous SBIR Phase I and II efforts by Ophirex to develop an intravenous snakebite treatment, with the goal of completing a Phase IIb clinical trial and regulatory approval for the treatment.
Quick answers
Who was awarded contract W81XWH19C0082?
W81XWH19C0082 was awarded to Ophirex, Inc. by Medical Command (Department of the Army) on August 5, 2019.
How much is contract W81XWH19C0082 worth?
The government has obligated $1,525,195 on W81XWH19C0082.
Was contract W81XWH19C0082 competed?
The extent of competition for W81XWH19C0082 was full and open competition after exclusion of sources. The government received 14 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award